{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-002108","form_type":"8-K","ticker":"FEMY","cik":"0001339005","company_name":"FEMASYS INC","filed_at":"2022-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.043513+00:00","generated_at":"2026-06-27T16:46:11.627597+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Femasys appoints Wendy Perrow to board, replacing William Witte","bullets":["William Witte resigned from board effective Jan 19, 2022; no disagreement cited.","Wendy Perrow elected as Class II director, to serve on Compensation Committee.","Anne Morrisey added to Nominating and Governance Committee.","Perrow brings biotech leadership; previously CEO of AsclepiX and Alba Therapeutics.","Company advancing FemaSeed de novo trial and FemBloc pivotal trial in 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-002108","json":"https://secwatch.observer/filing/0001140361-22-002108.json","markdown":"https://secwatch.observer/filing/0001140361-22-002108.md","text":"https://secwatch.observer/filing/0001140361-22-002108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1339005/000114036122002108/0001140361-22-002108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1339005/000114036122002108/brhc10032968_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:46:11.627597+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"003e26aad9","claim":"William Witte resigned as Director at FEMASYS INC.","evidence_excerpt":"Effective January 19, 2022, the Board of Directors of Femasys Inc. (the “Company”) accepted William Witte’s resignation from the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036122002108/0001140361-22-002108-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b237cc5720","claim":"Wendy Perrow was elected as Director at FEMASYS INC.","evidence_excerpt":"the Board of Directors elected Wendy Perrow as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036122002108/0001140361-22-002108-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}